Routine Genetic Testing of Germline Breast Cancer Susceptibility ─ Challenges and Opportunities

Routine Genetic Testing of Germline Breast Cancer Susceptibility ─ Challenges and Opportunities

Information on germline BRCA (g*BRCA*) 1/2 pathogenic or likely pathogenic mutations has predictive value for response to platinating agents and poly(ADP-ribose) polymerase inhibitors (PARPi) and survival outcomes of breast cancer (BC) patients. In the OlympiA trial, the benefits of adjuvant olapari...

Full description

Saved in:
Bibliographic Details
Main Authors: Cornelia Leo, Kathrin Schwedler, Rosaria Condorelli, Nicole Bürki, Jens Huober, Khalil Zaman, Christian Kurzeder, Marcus Vetter
Format: Article
Language:English
Published: THE HEALTHBOOK COMPANY LTD. 2023-10-01
Series:healthbook TIMES. Oncology Hematology
Online Access:https://doi.org/10.36000/HBT.OH.2023.17.117
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items